Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 401-407

  Laredo, James ^a   Shah, Jui R ^a   Lu, Zhuo Ren ^a   Hamilton, Bruce P ^a   Hamlyn, John M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

adrenal; angiotensin antagonists; cardiac glycosides; CGP42112; DuP753; losartan; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; HYDROCORTISONE; LOSARTAN POTASSIUM; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; OUABAIN;

ADAPTATION; ADRENAL CORTEX CELL; ALDOSTERONE RELEASE; ANIMAL CELL; ARTICLE; CATTLE; CELL SECRETION; CONTROLLED STUDY; HYDROCORTISONE RELEASE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SODIUM RESTRICTION;

EID: 0031017359     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.401     Document Type: Article

References (47)

1. Peach MJ, Dostal DE. The angiotensin II receptor and the action of angiotensin II. J Cardiovasc Pharmacol. 1990;16(suppl 4):S25-S30.
2. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
3. Murphy TJ, Alexander RN, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin-II receptor. Nature. 1991;351:233-236.
4. Mukoyama M, Nakajima M, Horiuchi M, Saamura H, Pratt RE, Dzau V. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors. J Biol Chem. 1993; 268:24539-24542.
5. Kambayashi Y, Bardham S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
6. Balla T, Baukal AJ, Eng S, Catt KJ. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol. 1991;40:401-406.
7. Quali R, LeBrethon MC, Saez JM. Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells. Endocrinology. 1993;133: 2766-2772.
8. Timmermans PBMWM, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens. 1992;5:221S-235S.
9. Buisson B, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD. The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells. FEBS Lett. 1992;309:161-164.
10. Jaiswal N, Tallant EA, Diz DI, Khosia MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991;17:1115-1120.
11. 2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun. 1992;183:206-211.
12. Kambayashi Y, Bardhan S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin type 2 receptor in cultured rat vascular smooth muscle cells. Biochim Biophys Acta. 1993;194:478-482.
13. Tamura M, Lam T-T, Inagami T. Isolation and characterization of a specific endogenous Na,K-ATPase inhibitor from bovine adrenal. Biochemistry. 1988;27:4244-4253.
14. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991;88:6259-6263.
15. Goto A, Yamada K, Yagi N, Hui C, Nagoshi H, Sasabe M, Yoshioka M. Digitalis-like factors from human urine. J Cardiovasc Pharmacol. 1993;22(suppl 2):S58-S59.
16. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, Ludens JH. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension. 1991; 17:930-935.
17. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo L-C, Berova N, Nakanishi K, Haber E, Haupert GT. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A. 1993;90:8189-8193.
18. Zhao N, Lo L-C, Berova N, Nakanishi K, Tymiak AA, Ludens JH, Haupert GT. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry. 1995;34:9893-9896.
19. Ludens JH, Clark MA, Robinson FG, DuCharme DW. Rat adrenal cortex is a source of circulating ouabainlike compound. Hypertension. 1992;19:721-724.
20. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among circulating and tissue ouabain and blood pressure. J Hypertens. 1994;12:549-560.
21. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology. 1994;135:794-797.
22. Laredo J, Hamilton BP, Hamlyn JM. Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun. 1995;212: 487-493.
23. Boulanger BR, Lilly MP, Hamlyn JM, Laredo J, Shurtleff D, Gann DS. Ouabain is secreted by the adrenal gland in awake dogs. Am J Physiol. 1993;264:E413-E419.
24. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, DuCharme DW. Development of an immunoassay for endogenous digitalis-like factor. Hypertension. 1991;17:936-943.
25. Jacoby SLS, Kowalik JS, Pizzo JT. Iterative Methods for Non-Linear Optimization Problems. New York, NY: Prentice-Hall; 1972:261.
26. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Kinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 1990;38:370-377.
27. Aguilera G. Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol. 1992;90:53-60.
28. Quali R, Poulette S, Penhoat A, Saez JM. Characterization and coupling of angiotensin-II receptor subtypes in cultured bovine adrenal fasciculata cells. J Steroid Biochem Mol Biol. 1992;43:271-280.
29. 1 receptor subtype. Endocrinology. 1993;132:2206-2212.
30. Rainey WE, Byrd W, Sinnokrot RA, Carr BR. Angiotensin-II activation of cAMP and corticosterone production in bovine adrenocortical cells: effects of nonpeptide angiotensin-II antagonists. Mol Cell Endocrinol. 1991;81:33-41.
31. Doris PA, Hayward-Lester A, Bourne D, Stocco DM. Ouabain production by cultured adrenal cells. Endocrinology. 1996;137:533-539.
32. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;163:284-291.
33. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Lett. 1993;321:184-188.
34. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin receptor subtypes. Biochem Biophys Res Commun. 1989;165:196-203.
35. Glossmann H, Baukal AJ, Catt KJ. Properties of angiotensin II receptors in bovine and rat adrenal cortex. J Biol Chem. 1974; 249:825-834.
36. Birnbaumer L. G proteins in signal transduction. Annu Rev Pharmacol Toxicol. 1990;30:675-705.
37. Bell FR, Doris PA, Simmonds A. Regulation of endogenous systemic and brain angiotensin II, arginine vasopressin and prolactin with the genesis of salt appetite in cattle. Neuroendocrinology. 1988;48:217-222.
38. Gottlieb SS, Ziskind AA, Lauria SS, Rodriguez S, Manunta P, Cines M, Krichten CM, Hamlyn JM. Endogenous ouabain is produced in the adrenal gland in patients with congestive heart failure. Circulation. 1993;88(part 2):I-255. Abstract.
39. Mizuno K, Hoffman LH, McKenzie JC, Inagami T. Presence of renin secretory granules in rat adrenal gland and stimulation of renin secretion by angiotensin II but not by adrenocorticotropin. J Clin Invest. 1988;82:1007-1016.
40. Tokita Y, Oda H, Franco-Saenz R, Mulrow PJ. Role of the tissue renin angiotensin system in the action of angiotensin-converting enzyme inhibitors. Proc Soc Exp Biol Med. 1995;208:391-396.
41. 1) and angiotensin II function in the rat adrenal zona glomerulosa cell. Adv Exp Med Biol. 1995;377:319-329.
42. 2)-9-ketoreductase activity in conscious rats. Hypertension. 1996;28:P83. Abstract.
43. Chang RSL, Lotti VJ. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands. Mol Pharmacol. 1990;29:347-351.
44. Denton DA. In: The Hunger for Salt: An Anthropological, Physiological and Medical Analysis. New York, NY: Springer Verlag; 1984:1-650.
45. Sekihara H, Yazaki Y, Kojima T. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Endocrinology. 1992;131:3077-3082.
46. Hamlyn JM, Hamilton BP, Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and an hypothesis. J Hypertens. 1996;14:151-167.
47. Rossi GP, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood prepare. J Hypertens. 1995;13:1181-1191.